Clinical trial
VAST - Ventricular Arrhythmia Suppression Trial
NCT00158912 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00158912 |
|---|---|
| Title | VAST - Ventricular Arrhythmia Suppression Trial |
| Official title | Ventricular Arrhythmia Suppression Trial |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tachycardia |
| Intervention type | Device |
| Interventions | Implantable Cardioverter Defibrillator |
| Enrollment | 550 |
| Start date | Aug 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 22, 2006 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: